📌NIH #COVIDー19 TREATMENT GUIDELINES
🚨What’s New?
🩸Antithrombotic Therapy
•Non-🏥👥 anticoagulants & antiplatelet should not be initiated
•🏥👥VTE prophylaxis per the SOC
🚫Routine therapeutics doses
💊Remdesivir
✅Severe
🚫Mild or moderate
💉 Convalescent Plasma & IVIG
🚨What’s New?
🩸Antithrombotic Therapy
•Non-🏥👥 anticoagulants & antiplatelet should not be initiated
•🏥👥VTE prophylaxis per the SOC
🚫Routine therapeutics doses
💊Remdesivir
✅Severe
🚫Mild or moderate
💉 Convalescent Plasma & IVIG
💉 Interleukin-6 Inhibitors
Diagnosis:
🤧nasopharynx samples
•High likelihood of infection based on exposure history📋&/or clinical presentation 🤧🤒, a single negative test does not completely exclude SARS-CoV-2 infection
🔬rt-PCR
🗣Transmission from asymptomatic individuals
Diagnosis:
🤧nasopharynx samples
•High likelihood of infection based on exposure history📋&/or clinical presentation 🤧🤒, a single negative test does not completely exclude SARS-CoV-2 infection
🔬rt-PCR
🗣Transmission from asymptomatic individuals
🚫Does not recommend the use of any agents for SARS-CoV-2 pre-exposure prophylaxis (PrEP) outside the setting of a clinical trial
🤔🤵🏿⚰️HCQ prophylaxis
⏰RCTs are in development or underway
🦠
🤔🤵🏿⚰️HCQ prophylaxis
⏰RCTs are in development or underway
🦠
🦠 MILD ILLNESS
🚨 let it go
Does not recommend any antiviral or imunomodulatory therapy
🚨 let it go
Does not recommend any antiviral or imunomodulatory therapy
